Megan A. Griffey, Ph.D. - Publications

Affiliations: 
2004 Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular genetics

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Galvin N, Vogler C, Levy B, Kovacs A, Griffey M, Sands MS. A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 11: 185-92. PMID 17990914 DOI: 10.2350/07-03-0242.1  0.614
2007 Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiology of Disease. 25: 150-62. PMID 17046272 DOI: 10.1016/J.Nbd.2006.09.001  0.606
2006 Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM, Wentz AE, Cooper JD, Sands MS. CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 538-47. PMID 16364693 DOI: 10.1016/J.Ymthe.2005.11.008  0.655
2005 Griffey M, Macauley SL, Ogilvie JM, Sands MS. AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 413-21. PMID 15979943 DOI: 10.1016/J.Ymthe.2005.04.018  0.604
2004 Griffey M, Bible E, Vogler C, Levy B, Gupta P, Cooper J, Sands MS. Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Neurobiology of Disease. 16: 360-9. PMID 15193292 DOI: 10.1016/J.Nbd.2004.03.005  0.63
2004 Griffey M, Wozniak D, Wong M, Rothman S, Bible E, Cooper J, Vogler C, Sands M. AAV-mediated gene therapy causes functional improvements in a murine model of infantile neuronal ceroid lipofuscinosis (INCL, Batten disease) Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.065  0.633
Show low-probability matches.